So you know your small molecule from your AAV, but can you unscramble the names of these 2024 novel drug approvals?

Alcami experts discuss what’s needed to accelerate drug development.

EU-based associations voice concerns over joint clinical assessments and the lack of advice meetings.

From wearable health tech to telehealth, here’s how digital transformation could impact the pharma industry and patient access.

A partnership between WhiteLab Genomics and Debiopharm will seek to use AI to streamline the development of targeted cancer therapies.

Why a forward-thinking approach is crucial for patient safety and industry success

A rundown of the latest developments and approvals in the world of small molecules drugs manufacturing.

A Pistoia Alliance survey looks at stakeholder concerns in AI regulations, and calls for more harmonization and collaboration.

How next-generation drug delivery and advanced automation are set to transform pharma’s future.

How will digitalization and automation redefine pharma manufacturing in the next decade?